Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation.

MLA

Iafusco, Dario, et al. “Case Report: Coeliac Disease as a Cause of Secondary Failure of Glibenclamide Therapy in a Patient with Permanent Neonatal Diabetes Due to KCNJ11/R201C Mutation.” Diabetologia, vol. 64, no. 7, July 2021, pp. 1703–06. EBSCOhost, https://doi.org/10.1007/s00125-021-05454-y.

APA

Iafusco, D., Zanfardino, A., Piscopo, A., Casaburo, F., De Nigris, A., Alfiero, S., Russo, G., Arenella, M., Russo, M. C., & Barbetti, F. (2021). Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation. Diabetologia, 64(7), 1703–1706. https://doi.org/10.1007/s00125-021-05454-y

Chicago

Iafusco, Dario, Angela Zanfardino, Alessia Piscopo, Francesca Casaburo, Angelica De Nigris, Salvatore Alfiero, Giuseppina Russo, Mattia Arenella, Maria Cecilia Russo, and Fabrizio Barbetti. 2021. “Case Report: Coeliac Disease as a Cause of Secondary Failure of Glibenclamide Therapy in a Patient with Permanent Neonatal Diabetes Due to KCNJ11/R201C Mutation.” Diabetologia 64 (7): 1703–6. doi:10.1007/s00125-021-05454-y.